Patient empowerment begins with understanding how RA can be diagnosed and managed. These materials provide a helpful overview of RA, including disease characteristics and some types of therapies that may be used to manage it.
Treat-to-Target (T2T) emphasizes the process of shared decision-making between patients and members of the medical team. Shared decision-making can only happen if patients are well informed about RA and their treatment options and communicate their expectations. The educational information on this site may help patients be better prepared to discuss their treatment choices, goals, and objectives with their HCPs.
Patient Instruction Guide: How to Use the RAPID3
This guide helps patients learn how to use the RAPID3 (Routine Assessment of Patient Index Data 3) form to calculate a RAPID3 score. The RAPID3 survey converts patients' answers on how RA is affecting them into a numerical score that can be used to monitor RA disease activity over time.
How to Use the RAPID3 Questionnaire (Instructional Video)a
Explore the RAPID3 self-assessment questionnaire and how to use it to calculate the RAPID3 score. This video provides step-by-step instructions on how to complete the RAPID3 Questionnaire, as well as how to record information for discussion with healthcare professionals.
Play Video (English version)
Play Video (Spanish version)
This self-assessment questionnaire generates information to help calculate a RAPID3 score and provides an explanation of those numerical results. Patients can write down their scores and bring the information to their next doctor's appointment.
RAPID3 Patient Tracker
This logbook enables you to record your RAPID3 scores, based on the RAPID3 questionnaire, to monitor your RA disease activity and identify important information for discussion with your healthcare professional.
Reproduction or distribution of this material is strictly prohibited without permission.
The RAPID3 system, and all copyright and trademark rights related thereto, is owned by Theodore Pincus and incorporated herein under license.